Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 7,400 shares, a decline of 45.6% from the January 15th total of 13,600 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an average trading volume of 1,150,000 shares, the short-interest ratio is presently 0.0 days.
Arcadia Biosciences Trading Down 1.5 %
Shares of RKDA traded down $0.07 during trading hours on Thursday, reaching $4.74. The stock had a trading volume of 2,027 shares, compared to its average volume of 13,377. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The company has a market capitalization of $6.45 million, a price-to-earnings ratio of -1.11 and a beta of 0.88. The firm has a 50-day simple moving average of $5.49 and a 200 day simple moving average of $3.92.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on shares of Arcadia Biosciences in a research note on Tuesday. They set a “sell” rating on the stock.
Institutional Investors Weigh In On Arcadia Biosciences
An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent SEC filing. Institutional investors and hedge funds own 17.73% of the company’s stock.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- The Significance of Brokerage Rankings in Stock Selection
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What is Insider Trading? What You Can Learn from Insider Trading
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- How to Short Nasdaq: An Easy-to-Follow Guide
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.